Aro Biotherapeutics, a clinical-stage biotechnology company developing potent and tissue-targeted short-interfering RNA (siRNA) medicines, today announced interim data from a phase 1b study of ABX1100 ...
Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful ...
Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...
In a recent study published in the Proceedings of the National Academy of Sciences (PNAS), researchers at the Texas A&M ...
In a recent study, researchers at the Texas A&M University Health Science Center (Texas A&M Health) identify a novel RNA ...
The immune system function declines with age, but a team of MIT researchers may have found a way to rejuvenate it. When older ...
For decades, aging has looked like an unavoidable slide into frailty, driven in part by an immune system that slowly loses ...
Benitec Biopharma Inc. reports 100% responder rates for BB-301 with a mid-2026 FDA meeting ahead. See why BNTC stock is upgraded to buy.
In a leap that blurs the line between science fiction and cellular biology, scientists have turned a mysterious structure ...
Vaults are mysterious cellular structures that can be genetically engineered to store information about a cell’s history.
The process by which glycoRNAs are created and deployed to the cell surface has been identified by Boston Children’s Hospital researchers.
As we age, the immune system gradually declines in function, leaving the body more vulnerable to disease. Scientists have discovered a new way to rejuvenate a key component of immune function, ...